Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials

Cited by (208)

Items 101–200 of 208

  1. Efficacy and Tolerability of Different Interventions in Children and Adolescents with Attention Deficit Hyperactivity Disorder
    Luan, Ruiling, Mu, Zhiling, Yue, Fang, He, Shaoying · 2017 · Frontiers in Psychiatry
  2. Outcomes of a 12-week ecologically valid observational study of first treatment with methylphenidate in a representative clinical sample of drug naïve children with ADHD
    Kristine Kaalund-Brok, Tine Houmann, Marie Bang Hebsgaard, Maj-Britt Glenn Lauritsen, Louise Hyldborg Lundstrøm, Helene Grønning, Lise Darling, Susanna Reinert-Petersen, Morten Aagaard Petersen, Jens Richardt Møllegaard Jepsen et al. · 2021 · PLoS ONE
  3. Improvement of anxiety in ADHD following goal-focused cognitive remediation: a randomized controlled trial
    K. T. Hanssen, Erlend Joramo Brevik, Milada Cvancarova Småstuen, Jan Stubberud · 2023 · Frontiers in Psychology
  4. Acute and long-term effects of adolescent methylphenidate on decision-making and dopamine receptor mRNA expression in the orbitofrontal cortex
    Leslie Renee Amodeo, Eliza Jacobs-Brichford, Matthew Stephen McMurray, Jamie D. Roitman · 2017 · Behavioural Brain Research
  5. Aufmerksamkeitsdefizit‑/Hyperaktivitätsstörung
    Oskar G. Jenni · 2016 · Monatsschrift Kinderheilkunde
  6. Evidence on methylphenidate in children and adolescents with ADHD is in fact of ‘very low quality’
    Ole Jakob Storebø, Morris Zwi, Helle B. Krogh, Carlos Renato Moreira Maia, Mathilde Holmskov, Donna M. Gillies, Camilla Groth, Erik Hertel Simonsen, Christian Nyfeldt Gluud · 2016 · Evidence-Based Mental Health
  7. The Home Observation Measure of the Environment is associated with symptoms of ADHD and oppositionality in a CAMHS sample
    W. W. Lai, Michelle O’Mahony, Aisling Mulligan · 2017 · Clinical Child Psychology and Psychiatry
  8. Autonomic Nervous System Functioning in ADHD
    Alessio Bellato, Jan Roelf Wiersema, Madeleine Jane Groom · 2023 · Autism and child psychopathology series
  9. Effect of pharmacological treatment of attention-deficit/hyperactivity disorder on later psychiatric comorbidity: a population-based prospective long-term study
    Ingvild Lyhmann, Tarjei Widding‐Havneraas, Ingvar Bjelland, Simen Markussen, Felix Elwert, Ashmita Chaulagain, Arnstein Mykletun, Anne Halmøy · 2024 · BMJ Mental Health
  10. Medicaid Prior Authorization Policies for Medication Treatment of Attention-Deficit/Hyperactivity Disorder in Young Children, United States, 2015
    Rachel L. Hulkower, Meghan Kelley, Lindsay K. Cloud, Susanna N. Visser · 2017 · Public Health Reports
  11. Complementary effects of pine bark extract supplementation on inattention, impulsivity, and antioxidative status in children with attention‐deficit hyperactivity disorder: A double‐blinded randomized placebo‐controlled cross‐over study
    Cheng‐Dien Hsu, Li‐Hsuan Hsieh, Yaling Chen, I‐Cheng Lin, Ying‐Ru Chen, Chih‐Chi Chen, Hitoshi Shirakawa, Suh‐Ching Yang · 2021 · Phytotherapy Research
  12. Treatment with Methylphenidate for Attention Deficit Hyperactivity Disorder (ADHD) and the Risk of All-Cause Poisoning in Children and Adolescents: A Self-Controlled Case Series Study
    Le Gao, Kenneth K. C. Man, Esther W. Chan, Celine Sze Ling Chui, Xue Li, David Coghill, Kam‐Lun Ellis Hon, Man Li Tse, Terry Yat Sang Lum, Kirstie H. T. W. Wong et al. · 2021 · CNS Drugs
  13. Self-Control in Responsibility Enhancement and Criminal Rehabilitation
    Polaris Koi, Susanne Uusitalo, Jarno Tuominen · 2017 · Criminal Law and Philosophy
  14. Prepubertal methylphenidate leads to sex-dependent differences in probabilistic discounting
    Gabrielle Kelly, Jessica C. Bezenah, Alexandra N. Tejada, Benjamin Johnson, Briana Vazquez, Melissa Espinosa, Leslie Renee Amodeo · 2022 · Pharmacology Biochemistry and Behavior
  15. Risk of Mania After Methylphenidate in Patients With Bipolar Disorder
    Oskar Hougaard Jefsen, Søren Dinesen Østergaard, Christopher Rohde · 2022 · Journal of Clinical Psychopharmacology
  16. Response Trajectories and Temporal Trends of Viloxazine Treatment for Young People With ADHD
    Chia‐Ling Yu, Yu‐Chen Kao, Trevor Thompson, Brendon Stubbs, Ping‐Tao Tseng, Chih-Wei Hsu, Fu‐Chi Yang, Yu‐Kang Tu, Tien‐Wei Hsu, Chih‐Sung Liang · 2024 · JAMA Network Open
  17. Prescription psychostimulants as a harm reduction and treatment intervention for methamphetamine use disorder and the implications for nursing clinical practice: A scoping review of the literature
    Don M. Leidl, Pearl Takhar, Hua Li · 2023 · International Journal of Mental Health Nursing
  18. Methylphenidate dose–response behavioral and neurophysiological study of the ventral tegmental area and nucleus accumbens in adolescent rats
    Elzia Broussard, Cruz Reyes-Vázquez, Nachum Dafny · 2019 · European Journal of Neuroscience
  19. Evaluating Therapeutic Effects of ADHD Medication Objectively by Movement Quantification with a Video-Based Skeleton Analysis
    Chen‐Sen Ouyang, Yi-Hung Chiu, Ching‐Tai Chiang, Rong‐Ching Wu, Ying-Tong Lin, Rei‐Cheng Yang, Lung‐Chang Lin · 2021 · International Journal of Environmental Research and Public Health
  20. Clinical Investigation of French Maritime Pine Bark Extract on Attention-Deficit Hyperactivity Disorder as compared to Methylphenidate and Placebo: Part 1: Efficacy in a Randomised Trial
    Anne-Sophie Weyns, Annelies A. J. Verlaet, Annelies Breynaert, Tania Naessens, Erik Fransén, Hélène Verhelst, Dirk Van West, Ingrid Van Ingelghem, An I. Jonckheere, Diane Beysen et al. · 2022 · Journal of Functional Foods
  21. Clinical Investigation of French Maritime Pine Bark Extract on Attention-Deficit Hyperactivity Disorder as compared to Methylphenidate and Placebo: Part 2: Oxidative Stress and Immunological Modulation
    Anne-Sophie Weyns, Annelies A. J. Verlaet, Maxim Van Herreweghe, Annelies Breynaert, Erik Fransén, Ingrid De Meester, Emilie Logie, Wim Vanden Berghe, Hélène Verhelst, Dirk Van West et al. · 2022 · Journal of Functional Foods
  22. Methylphenidate for ADHD
    Mina S. Fazel · 2015 · BMJ
  23. The Effects of Crocus sativus (Saffron) on ADHD: A Systematic Review
    Sepideh Seyedi Sahebari, Sara Farhang, Mostafa Araj‐Khodaei, Shahin Akhondzadeh, Amirreza Naseri, Sarvin Sanaie, Negin Frounchi · 2023 · Journal of Attention Disorders
  24. Impaired reproduction after exposure to ADHD drugs: Systematic review of animal studies
    Pia Brandt Danborg, Anders Lykkemark Simonsen, Peter Christian Gøtzsche · 2017 · International Journal of Risk & Safety in Medicine
  25. Teachers’ role and attitudes concerning ADHD medication: A qualitative analysis
    Maruschka N. Sluiter, Albert W. Wienen, Ernst D. Thoutenhoofd, Jeannette M. Doornenbal, Laura Batstra · 2019 · Psychology in the Schools
  26. Acute Tolerability of Methylphenidate in Treatment-Naïve Children with ADHD: An Analysis of Naturalistically Collected Data from Clinical Practice
    Gabriele Masi, Chiara Pfanner, Francesca Liboni, Francesca Lenzi, Arianna Villafranca, Giulia D’Acunto, Pamela Fantozzi, Francesca Falcone, Valerio Simonelli, Pietro Muratori et al. · 2022 · Pediatric Drugs
  27. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
    Ole Jakob Storebø, Maja Rosenberg Overby Storm, Johanne Pereira Ribeiro, Maria Skoog, Camilla Groth, Henriette Edemann-Callesen, Julie Perrine Schaug, Pernille Juul Darling, Christel-Mie Lykke Huus, Morris Zwi et al. · 2025 · Cochrane Database of Systematic Reviews
  28. Effects of methylphenidate on mitochondrial dynamics and bioenergetics in the prefrontal cortex of juvenile rats are sex-dependent
    Alessandra Schmitt Rieder, Osmar Vieira Ramires Júnior, Gustavo Ricardo Krupp Prauchner, Ângela Terezinha de Souza Wyse · 2024 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  29. Symptômes psychiatriques aigus lors d’injections intraveineuses de méthylphénidate : à propos d’un cas
    Fabrice Verite, Joëlle Micallef · 2016 · Therapies
  30. Potential Negative Effects of Dextromethorphan as an Add-On Therapy to Methylphenidate in Children With ADHD
    Wei-Chen Chuang, Chin‐Bin Yeh, Sheng-Chiang Wang, Pei‐Yin Pan, Jia‐Fwu Shyu, Yia‐Ping Liu, Susan Shur‐Fen Gau, Ru‐Band Lu · 2019 · Frontiers in Psychiatry
  31. What children and young people learn about ADHD from youth information books: A text analysis of nine books on ADHD available in Dutch
    Laura Batstra, Linda Foget, Caroline van Haeringen, Sanne te Meerman, Ernst D. Thoutenhoofd · 2020 · Scandinavian Journal of Child and Adolescent Psychiatry and Psychology
  32. Improving cognitive function in Chinese children with ADHD and/or RD through computerized working memory training
    Kean Poon, Mimi S. H. Ho, Li‐Chih Wang, Hee Min Lee, Way Kwok‐Wai Lau, Winnie Wai Lan Chan · 2024 · BMC Psychology
  33. Impact of a New Parent Behavioral-Schema Training on Children with ADHD: A Pragmatic Control Trial
    Maly Solan, Anat Brunstein Klomek, Galia Ankori, Asheda Bloch, Alan S. Apter, Sarit Plishty · 2020 · Journal of Attention Disorders
  34. Effect of vitamin D supplementation on brain waves, behavioral performance, nitric oxide, malondialdehyde, and high-sensitivity C-reactive protein in children with attention deficit/hyperactivity disorder: study protocol for a randomized clinical trial
    Abbas Ali Sangouni, Hamid Mirhosseini, Mahdieh Hosseinzadeh · 2022 · Trials
  35. Psychotherapy for Adolescents With Attention-Deficit Hyperactivity Disorder: A Pediatrician’s Guide
    Vania Modesto‐Lowe, Victoria Charbonneau, Pantea Farahmand · 2016 · Clinical Pediatrics
  36. Attention-deficit hyperactivity disorder: a critique of the concept
    Sami B. Timimi · 2018 · Irish Journal of Psychological Medicine
  37. Specialty knowledge and competency standards for pharmacotherapy for pediatric obsessive-compulsive disorder
    Bernhard Weidle, Tord Ivarsson, Fernando Ramos Asbahr, Rosa M Calvo, David Mataix‐Cols, Moira A. Rynn, Eric A. Storch · 2021 · Psychiatry Research
  38. Methylphenidate effects on P300 responses from children and adolescents
    Milaine Dominici Sanfins, Stavros Hatzopoulos A, Osmar Henrique Della Torre, Caroline Donadon, Piotr Henryk Skarzynski, Maria Francisca Colella‐Santos · 2017 · International Journal of Pediatric Otorhinolaryngology
  39. Psychostimulanzien und andere Arzneistoffe, die zur Behandlung der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) angewendet werden
    Susanne Walitza, Manfred Gerlach, Marcel Romanos, Tobias Renner · 2016 · Springer eBooks
  40. Health-related quality of life in cases of attention deficit hyperactivity disorder with and without pharmacological treatment
    José Antonio López Villalobos, Ana María Sacristán-Martín, Mercedes Garrido-Redondo, María Teresa Martínez‐Rivera, María Victoria López-Sánchez, Luis Rodríguez-Molinero, Ana Belén Camina-Gutiérrez, Jesús Andrés-de Llano · 2019 · Anales de Pediatría (English Edition)
  41. The Relationship Between Vitamin D and the Development and Treatment of Attention-Deficit Hyperactivity Disorder: An Overview of Systematic Reviews
    Razi Kitaneh, Laya Jalilian Khave, Binah Baht Ysrayl, Anna Borelli, Melissa Christine Funaro, Marc Nicholas Potenza, Gustavo A. Angarita · 2024 · Current Behavioral Neuroscience Reports
  42. Efficacy of an Intervention Program for Attention and Reflexivity in Children With Attention Deficit Hyperactivity Disorder
    Yoana Campeño Martínez, Sandra Santiago‐Ramajo, Enrique Navarro Asencio, Esperanza Vergara‐Moragues, Víctor Santiuste Bermejo · 2017 · Mind Brain and Education
  43. Le TDAH chez les enfants et les adolescents, partie 2 : le traitement
    Mark E Feldman, Alice Charach, Stacey A Bélanger · 2018 · Paediatrics & Child Health
  44. Investigating the effects of age, IQ, dosing, and anthropometric measures on the treatment persistence in long-term methylphenidate use
    Mustafa Tunçtürk, Çağatay Ermiş, Dicle Büyüktaşkın, Eren Halaç, Ekin Süt, Oben Ozkan, Nazan Gundogan, Guldal Unutmaz, Remzi Oğulcan Çıray, Serkan Turan et al. · 2022 · Nordic Journal of Psychiatry
  45. Attention-deficit hyperactivity disorder (ADHD): progress and controversy in diagnosis and treatment
    David Martin Foreman, Sami B. Timimi · 2018 · Irish Journal of Psychological Medicine
  46. Recovery and inference of causal effects with sequential adjustment for confounding and attrition
    Johan de Aguas, Johan Pensar, Tomás Varnet Pérez, Guido Biele · 2025 · Journal of Causal Inference
  47. Introduction
    Jamie L. Tully, Mark J. Forshaw, Matthew Hall, Catharine Montgomery · 2020 · Springer eBooks
  48. Fronto-Cerebellar Neurometabolite Alterations After Methylphenidate in Children and Adolescents With ADHD: A Proton Magnetic Resonance Spectroscopy Study
    Soroush Bakhshi, Mehdi Tehrani‐Doost, Seyed Amir Hossein Batouli · 2023 · Journal of Attention Disorders
  49. Duration of ADHD medication treatment among Finnish children and adolescents ‒ a nationwide register study
    Terhi A. Kolari, Miika A. Vuori, Hanna Rättö, Eveliina A. Varimo, Eeva T. Aronen, Kari J. Auranen, Leena Saastamoinen, Päivi T. Ruokoniemi · 2025 · European Child & Adolescent Psychiatry
  50. Why Are Long-term Benefits of Stimulant Medication So Difficult to Detect?
    Brooke S. G. Molina, James M. Swanson · 2020 · The ADHD Report
  51. Risks of Stimulant Use for Attention Deficit Hyperactivity Disorder on the Developing Brain: Primum non nocere
    H. Stern, J. Lipman, S. Andersen, John Bossaer, Jim C. Thigpen · 2017 · La Clinica pediatrica
  52. Psychopharmakotherapie – klinisch-empirische Grundlagen
    Hans‐Peter Volz, Siegfried F. Kasper, Hans‐Jürgen Möller · 2017 · Springer eBooks
  53. Verhaltenstherapie und psychopharmakologische Behandlung
    Hans‐Christoph Steinhausen · 2018 · Springer eBooks
  54. Plasma fatty acids and attention deficit hyperactivity disorder: a Mendelian randomization investigation
    Kangning Zhou, Qıang Zhang, Zhenhua Yuan, Yurou Yan, Qian Zhao, Junhong Wang · 2024 · Frontiers in Psychiatry
  55. Methylphenidate as a Novel Adjunct in Opioid-Taking Patients: Insights into Dopaminergic Neuroadaptation and Hypoactive Delirium
    N. Świderski, Patryk Rodek, Krzysztof Kucia · 2025 · Brain Science
  56. The efficacy and safety of electrical acupoint stimulation (EAS) for knee osteoarthritis (KOA): A GRADE-assessed systematic review, meta-analysis and trial sequential analysis
    Guangyi Yang, Rong Zhang, Botan Xu, Yi Yang, Yuxuan Wang, Wenjing Xu, Pengwei Li, Aotian Yu, Simin Ning, Qixuan Fu et al. · 2025 · PLoS ONE
  57. Trastorno por Déficit de Atención con Hiperactividad: revisión del tratamiento psicológico
    José Antonio López Villalobos · 2019 · ReiDoCrea Revista electrónica de investigación Docencia Creativa
  58. The efficacy, ethics, & pitfalls of stimulants for justice system involved individuals
    Brian B. Boutwell, Nicholas Kavish, Chelsey S. Narvey · 2020 · Neuroscience & Biobehavioral Reviews
  59. Systematic Reviews of Nonrandomized Studies of Interventions
    Jelena Savović, Penny F. Whiting, Olaf M. Dekkers · 2022 · Wiley eBooks
  60. Nonadherence in Childhood Disorders: Attention-Deficit/Hyperactivity Disorder
    Joseph C. Blader · 2019 · Springer eBooks
  61. Methylphenidate: A Review
    Vinicius Faustino Lima de Oliveira, Danilo José Silva Moreira, Juliana Brito da Fonseca, Karoline Rossi, Suzana dos Santos Vasconcelos, Cláudio Alberto Gellis de Mattos Dias, Euzébio de Oliveira, Carla Viana Dendasck, Maria Helena Mendonça de Araújo, Amanda Alves Fecury · 2021 · Revista Científica Multidisciplinar Núcleo do Conhecimento
  62. Attention Deficit Hyperactivity Disorder (ADHD)
    Carlin J. Miller · 2016 · Springer eBooks
  63. Editorial: The diagnosis and the therapy of social cognition deficits in adults affected by ADHD and MCI
    Leonardo Sacco, Lucia Morellini, Chiara Cerami · 2023 · Frontiers in Neurology
  64. Psychotherapieforschung mit Kindern und Jugendlichen
    Michael W. Lippert, Silvia Schneider · 2018 · Springer eBooks
  65. Active suicidal ideation in an adolescent with autism spectrum disorder receiving methylphenidate: a case report
    A. Kerkeni, Charles Olivier Pons · 2024 · Middle East Current Psychiatry
  66. Methylphenidate leads to disruptions in rest/wake patterns after discontinuation
    C. R. del Cueto, Magdalena R. Gonzales, Alexandra N. Tejada, Kimberly Leon, Alexandra Mora, Andrew Cabrera, Leslie Renee Amodeo · 2025 · Psychopharmacology
  67. Duration effects of micronutrients in children with ADHD: Randomised controlled trial vs. Open-Label extension
    Adarsh Chand, Kathryn A. Darling, Julia J. Rucklidge · 2025 · European Child & Adolescent Psychiatry
  68. P-OCA
    Eva Charlotte Merten, Johanna Schoppmann, Julia Brailovskaia, Silvia Schneider · 2026 · Kindheit und Entwicklung
  69. Amphetamines for attention deficit hyperactivity disorder in children and adolescents
    Mark E. Feldman · 2017 · Paediatrics & Child Health
  70. Remédiation cognitive dans le TDA/H
    Pierre Fourneret · 2017
  71. The egg or the hen: Is ADHD the result of attachment problems – or do attachment problems arise from ADHD?
    Pernille Darling Rasmussen · 2018 · Scandinavian Journal of Child and Adolescent Psychiatry and Psychology
  72. A influência do “modelo centrado na doença” no uso de medicamentos para problemas de aprendizagem na escola
    Fabíola Stolf Brzozowski · 2021 · Política & Sociedade
  73. The Attitudes, Beliefs and Knowledge of Non-Psychiatrist Physicians About Attention Deficit/ Hyperactivity Disorder and Methylphenidate Treatment
    Arif Önder, Özge Gizli Çoban · 2021 · Çocuk ve Gençlik Ruh Sağlığı Dergisi / Turkish Journal of Child and Adolescent Mental Health
  74. Metilfenidato: Uma Revisão
    Vinicius Faustino Lima de Oliveira, Danilo José Silva Moreira, Juliana Brito da Fonseca, Karoline Rossi, Suzana dos Santos Vasconcelos, Cláudio Alberto Gellis de Mattos Dias, Euzébio de Oliveira, Carla Viana Dendasck, Maria Helena Mendonça de Araújo, Amanda Alves Fecury · 2021 · Revista Científica Multidisciplinar Núcleo do Conhecimento
  75. Efficacy of methylphenidate treatment in childhood myotonic dystrophy type 1 and comorbid attention deficit hyperactivity disorder: A case report using eye tracking assessment
    Dirk J. J. Sweere, Jos G.M. Hendriksen, R. Jeroen Vermeulen, Sylvia Klinkenberg · 2023 · Brain and Development
  76. Should methylphenidate be included in the WHO model lists of essential medicines?
    Johanne Pereira Ribeiro, Christian Nyfeldt Gluud, Maja Rosenberg Overby Storm, Ole Jakob Storebø · 2024 · European Child & Adolescent Psychiatry
  77. Tratamiento del TDAH Dual: una Gota en el Desierto
    Ruth Cunill, Xavier Castells Cervelló · 2016 · Adicciones
  78. How to improve psychiatric services: a perspective from critical psychiatry
    Prasanna de Silva · 2017 · British Journal of Hospital Medicine
  79. Manipulations and Spins in Attention Disorders Research: The Case of ADHD and COVID-19
    Yaakov Ophir, Yaffa Shir-Raz · 2020 · Ethical Human Psychology and Psychiatry
  80. Neuropsychopharmacotherapy in Children and Adolescents
    Susanne Walitza, Gregor Emanuel Berger, DANIEL A. GELLER, Lukasz Smigielski · 2022 · Springer eBooks
  81. Sleep & attention profiles in children with Autism Spectrum Disorder
    Mistral Dawn Foster-Owens · 2017 · Figshare
  82. Quality of Life of Adult Patients With Attention-Deficit/Hyperactivity Disorder Taking Methylphenidate—Reply
    Alexandra Philipsen, Ludger Tebartz van Elst, Erika Graf · 2016 · JAMA Psychiatry
  83. WHO Essential Medicines List and methylphenidate for ADHD in children and adolescents
    Sébastien Ponnou, Sami B. Timimi, Xavier Briffault, Laura Batstra, Peter Christian Gøtzsche, François Gonon · 2024 · The Lancet Psychiatry
  84. Assessment of Cognitive Deficits and Sex Differences in Adult Rats after Adolescent Methylphenidate Exposure
    Rajaa Thalluri, Samantha M. Renaud, Megan E. Miller, Jessica L. Sharp · 2016 · OhioLink ETD Center (Ohio Library and Information Network)
  85. Brief report of efficacy and side effect profile of crossing over to modified-release capsules of methylphenidate in ADHD patients receiving other treatments: case series
    Burcu Özbaran, Sezen Köse, Fevzi Tuna Ocakoğlu, Hakan Kayış, Ayşegül Satar, Uğur Tekin · 2017 · Psychiatry and Clinical Psychopharmacology
  86. Methylphenidate Tied to Improved ADHD Symptoms in Kids
    Kelly D. Young, Physician's First Watch · 2015 · Journal watch
  87. Disturbo di deficit dell⬢attenzione/iperattività nel bambino: approccio medico
    M.-F. Le Heuzey · 2019 · EMC - AKOS - Trattato di Medicina
  88. Associated Psychiatric Disorders in Adults with High-Functioning ASD
    Shirley Portuguese · 2019 · Autism and child psychopathology series
  89. Methylphenidat: Ein Rückblick
    Vinicius Faustino Lima de Oliveira, Danilo José Silva Moreira, Juliana Brito da Fonseca, Karoline Rossi, Suzana dos Santos Vasconcelos, Cláudio Alberto Gellis de Mattos Dias, Euzébio de Oliveira, Carla Viana Dendasck, Maria Helena Mendonça de Araújo, Amanda Alves Fecury · 2021 · Revista Científica Multidisciplinar Núcleo do Conhecimento
  90. Metilfenidato: Una recensione
    Vinicius Faustino Lima de Oliveira, Danilo José Silva Moreira, Juliana Brito da Fonseca, Karoline Rossi, Suzana dos Santos Vasconcelos, Cláudio Alberto Gellis de Mattos Dias, Euzébio de Oliveira, Carla Viana Dendasck, Maria Helena Mendonça de Araújo, Amanda Alves Fecury · 2021 · Revista Científica Multidisciplinar Núcleo do Conhecimento
  91. Metilfenidato: una revisione
    Vinicius Faustino Lima de Oliveira, Danilo José Silva Moreira, Juliana Brito da Fonseca, Karoline Rossi, Suzana dos Santos Vasconcelos, Cláudio Alberto Gellis de Mattos Dias, Euzébio de Oliveira, Carla Viana Dendasck, Maria Helena Mendonça de Araújo, Amanda Alves Fecury · 2021 · Revista Científica Multidisciplinar Núcleo do Conhecimento
  92. Adolescent perceptions of factors related to engagement in ADHD care: A qualitative study at an urban safety net hospital
    Nicole Zolli · 2020
  93. Psychopharmakotherapie – klinisch-empirische Grundlagen
    Hans‐Peter Volz, Siegfried F. Kasper, H.‐J. Möller · 2015 · Springer eBooks
  94. Neuropsychopharmacotherapy in Children and Adolescents
    Susanne Walitza, Gregor Emanuel Berger, DANIEL A. GELLER, Lukasz Smigielski · 2022 · Springer eBooks
  95. Methylphenidate and attention‐deficit hyperactivity disorder
    2016 · Journal of Paediatrics and Child Health
  96. Electroencephalogram activity in attention-deficit hyperactivity disorder
    MaiA Shalaby, LamyaaG. E. Elhamrawya, MohamedS Abdel-Shafy · 2022 · Menoufia Medical Journal
  97. Effectiveness and underlying mechanism of the intervention for children with comorbidity between attention deficit hyperactivity disorder and developmental dyslexia
    Nan CUI, Jiuju WANG, Jing Zhao · 2022 · Advances in Psychological Science
  98. Remédiation cognitive dans le TDAH de l’enfant et de l’adolescent
    Christophe Gauld, Lucie Jurek, Pierre Fourneret · 2023 · Elsevier eBooks
  99. Exploring the therapeutic potential of French maritime pine bark extract in attention-deficit hyperactivity disorder and arterial stiffness
    Anne-Sophie Weyns · 2024
  100. Growth and use of methylphenidate in the child and adolescent population: Systematic review
    Marília Guimarães de Sousa Jota, Analía Claudia Sabattini · 2023 · SCT Proceedings in Interdisciplinary Insights and Innovations.